Please login to the form below
Incyte and Novartis join coronavirus efforts with phase 3 study
Ruxolitinib helps to inhibit immune cells from attacking the body’s own immune system
Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
Phase 1 trial was initiated in record time, after vaccine candidate fast-tracked by US government
Merck’s Keytruda beats chemo in first-line colorectal cancer
Achieved “clinically meaningful” improvement in progression-free survival
OSE lung cancer vaccine clears phase 3 hurdle, but COVID-19 stalls programme
Tedopi is aimed at stimulating T-lymphocytes against tumours
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
The pair of phase 3 trials will take place across 15 clinical sites in the UK
UK government reveals only 2,000 key NHS staff have been tested for coronavirus
Health officials face criticism over strict production measures
MHRA raises concerns over fraudulent coronavirus tests
As Amazon and Boots partner on at-home testing kits
BMS and bluebird bio file ide-cel CAR-T for multiple myeloma in US
Ide-cel has breakthrough designation from the FDA
Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs
The five-year deal includes Sitryx’ two lead projects
Current and future trends for developing digital medical communications
Evolving digital trends and user needs
-
Q&A: Kate PaxtonPME interview's JPA Health's senior VP
-
Q&A: Mike DixonPME interviews the CEO of the Healthcare Communications Association (HCA)
-
AZ’s Imfinzi gets US OK in small cell lung cancer, challenging TecentriqFirst checkpoint inhibitor to challenge Roche's Tecentriq in this indication
-
Amarin shares tumble following Vascepa patent lossJudgement invalidates six key patents on fish-oil derived med
-
J&J says COVID-19 vaccine could be ready in early 2021Also receives US federal backing to increase manufacturing for the shot
-
Bayer gets EU nod for prostate cancer drug Nubeqa Enters an increasingly competitive market
-
New study identifies drugs that are safe to use in COVID-19 treatmentResearchers find no evidence for or against the use of drugs like ibuprofen
-
Merck, Bayer flesh out vericiguat heart failure data at ACCDrug reduced rate of cardiovascular deaths and hospitalisations
-
FDA grants emergency authorisation to chloroquine for COVID-19Novartis and Bayer donate anti-malaria drugs to US stockpile
Latest appointments
-
Dan Russell joins Seven Stones as managing directorJoins the team to help drive global expansion
-
McCann Health France strengthens team with two new hires Melissa Brunet and Christelle David-Basei join the agency
-
Ashfield appoints new global head of quality and complianceInternal candidate Carey Galvin to take on the role
-
NICE looks internally for new chief executive Deputy chief exec Gillian Leng is set to take the helm
-
AstraZeneca taps internal candidate to become UK presidentTom Keith-Roach has worked at the company for 17 years
COVID-19 Updates and Daily News
Featured jobs
-
Account Manager (PR)
-
Great Benefits
-
Senior External Communications Lead
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Manager
-
£Competitive Salary
- UK, China prep trials of coronavirus vaccine candidates
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- China backs use of Roche’s Actemra for coronavirus
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Novartis donates malaria drug for COVID-19 clinical trials
- Moderna and GSK advance coronavirus vaccine candidates
- Incyte and Novartis join coronavirus efforts with phase 3 study
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Merck’s Keytruda beats chemo in first-line colorectal cancer
- “Fake News” and Credibility in Medical Publishing
- How Much Does Each Advisor “Insight” Actually Cost?
- It's not just our logo that's green
PMHub
huumun formerly PharmiWeb Solutions
huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...
Latest intelligence
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
- Pharma funding and M&A in 2020
- Why pharma M&A has continually bucked the trend...
Quick links
Infographics
